While our primary motivation was to test the role for Myh9&10 genes in renal epithelia and to use kidney as a model organ to study NM2-mediated specialized cellular transport pathways, we were also influenced by the fact that mutations in the MYH9 gene are associated with end-stage renal disease in human patients (35–37). Here, MYH9 is linked to stage 5 chronic kidney disease.